This company has been marked as potentially delisted and may not be actively trading.

Apellis Pharmaceuticals (APLS) Insider Trading & Ownership

Apellis Pharmaceuticals logo

Apellis Pharmaceuticals (NASDAQ:APLS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$14.51M
Get APLS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Apellis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APLS Insider Buying and Selling by Quarter

Apellis Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/11/2026Sell368$22.15$8,151.20  
1/22/2026Sell2,797$21.77$60,890.69  
1/22/2026Sell27,192$21.77$591,969.84  
1/22/2026
David O Watson
David O Watson
General Counsel
Sell7,832$21.77$170,502.64  
1/22/2026Sell2,064$21.77$44,933.28  
1/22/2026Sell3,371$21.77$73,386.67  
1/22/2026Sell7,725$21.77$168,173.25  
1/22/2026Sell5,928$21.77$129,052.56  
1/22/2026Sell10,287$21.77$223,947.99  
1/20/2026Sell1,882$19.79$37,244.78  
1/20/2026Sell8,182$19.79$161,921.78  
1/20/2026
David O Watson
David O Watson
General Counsel
Sell2,475$19.79$48,980.25  
1/20/2026Sell726$19.79$14,367.54  
1/20/2026Sell1,334$19.79$26,399.86  
1/20/2026Sell2,203$19.79$43,597.37  
1/20/2026Sell909$19.79$17,989.11  
1/20/2026Sell2,892$19.79$57,232.68  
1/13/2026Sell10,186$22.19$226,027.34  
1/13/2026
David O Watson
David O Watson
General Counsel
Sell5,780$22.19$128,258.20  
1/13/2026Sell873$22.19$19,371.87  
1/13/2026Sell1,780$22.19$39,498.20  
1/13/2026Sell2,618$22.19$58,093.42  
1/13/2026Sell2,277$22.19$50,526.63  
1/13/2026Sell3,856$22.19$85,564.64  
12/16/2025
David O Watson
David O Watson
General Counsel
Sell5,000$24.49$122,450.00  
11/17/2025
David O Watson
David O Watson
General Counsel
Sell5,000$20.06$100,300.00  
10/21/2025Sell10,000$28.03$280,300.00  
10/16/2025
David O Watson
David O Watson
General Counsel
Sell5,000$25.22$126,100.00  
10/10/2025Sell31,092$23.72$737,502.24  
9/19/2025Sell31,092$22.95$713,561.40  
9/16/2025
David O Watson
David O Watson
General Counsel
Sell5,000$24.34$121,700.00  
9/15/2025Sell189$24.19$4,571.91  
9/2/2025Sell548$28.08$15,387.84  
8/28/2025Sell49,963$28.39$1,418,449.57  
8/27/2025Sell175,037$28.19$4,934,293.03  
8/18/2025
David O Watson
David O Watson
General Counsel
Sell5,000$27.80$139,000.00  
7/17/2025Sell19,725$20.21$398,642.25  
7/16/2025
David O Watson
David O Watson
General Counsel
Sell5,000$19.55$97,750.00  
7/15/2025Sell1,900$20.09$38,171.00  
7/14/2025Sell137,465$20.19$2,775,418.35  
There’s a new type of capitalism (Ad)

The U.S. government has taken direct equity positions in at least 10 companies - Intel, U.S. Steel, Westinghouse, MP Materials, Lithium Americas, and others - plus roughly $2 billion in quantum computing investments. When these deals were announced, the stocks soared overnight. Porter Stansberry, founder of one of the world's largest financial research firms, says this shift away from free-market capitalism is the most consequential economic story in centuries - and almost no one is prepared for it. He's identified the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this new reality.tc pixel

See Porter Stansberry's full breakdown and investment recommendations now
(Data available from 1/1/2013 forward)

APLS Insider Trading Activity - Frequently Asked Questions

6.50% of Apellis Pharmaceuticals stock is owned by insiders. Learn more on APLS's insider holdings.

The following insiders have sold APLS shares in the last 24 months: A. Sinclair Dunlop ($4,243,453.64), Caroline Baumal ($193,344.43), Cedric Francois ($11,399,873.19), David O Watson ($1,618,745.74), James George Chopas ($180,419.28), Jeffrey Eisele ($9,661.47), Mark Jeffrey Delong ($157,795.95), Nur Nicholson ($478,619.88), Pascal Deschatelets ($197,568.30), and Timothy Eugene Sullivan ($871,240.87).

Insiders have sold a total of 747,665 Apellis Pharmaceuticals shares in the last 24 months for a total of $19,350,722.75 sold.



This page (NASDAQ:APLS) was last updated on 6/18/2026 by MarketBeat.com Staff.
From Our Partners